Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes

ObjectiveTo construct a prognostic model of lung adenocarcinoma (LUAD) based on m5C modification-related genes and to explore its clinical value. MethodsBased on the LUAD data in TCGA, GSE30219, GSE31210, and GSE50081 cohorts, prognosis-related m5C modification-related genes were screened, and the p...

Full description

Saved in:
Bibliographic Details
Main Authors: Fan YANG, Nongyan WANG, Meng FANG, Yingjiao ZHANG, Haiyan HU, Peng FANG
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2025-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0992
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850066753930919936
author Fan YANG
Nongyan WANG
Meng FANG
Yingjiao ZHANG
Haiyan HU
Peng FANG
author_facet Fan YANG
Nongyan WANG
Meng FANG
Yingjiao ZHANG
Haiyan HU
Peng FANG
author_sort Fan YANG
collection DOAJ
description ObjectiveTo construct a prognostic model of lung adenocarcinoma (LUAD) based on m5C modification-related genes and to explore its clinical value. MethodsBased on the LUAD data in TCGA, GSE30219, GSE31210, and GSE50081 cohorts, prognosis-related m5C modification-related genes were screened, and the prognostic model was constructed by using univariate Cox, Lasso, and multivariate Cox regression analyses. Kaplan-Meier curve, ROC curve, and Cox regression were used to observe the robustness and prognostic performance of the model. The correlation between the prognostic model and clinicopathologic features was further explored. ResultsA prognostic model consisting of eight m5C modification-related genes, including CDK1, CDKN1A, NOP2, RRM2, TCL6, TLR8, TRDMT1, and YTHDF2, was constructed. Risk score was an independent risk factor for the prognosis of patients with LUAD, and it is combined with age, T stage, and N stage to constitute a nomogram which can accurately predict the prognosis of patients. The infiltration of macrophages and CD4+/CD8+T cells was significantly reduced in high-risk patients. The risk score in LUAD tissues was significantly higher than that in normal tissues and was positively correlated with T stage and N stage. The risk score of smoking and EGFR wild-type patients was higher than that of non-smoking and EGFR-mutant patients. ConclusionThe prognostic model constructed based on m5C modification-related genes has shown good accuracy and stability in predicting the prognosis of patients with LUAD, and it is closely related to clinical features, driver gene mutations, and immune infiltration, which can provide a potential basis for the treatment and prognostic assessment of LUAD.
format Article
id doaj-art-0b72abdec7dc4bff89056d5d5f005d01
institution DOAJ
issn 1000-8578
language zho
publishDate 2025-03-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj-art-0b72abdec7dc4bff89056d5d5f005d012025-08-20T02:48:39ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782025-03-0152320821610.3971/j.issn.1000-8578.2025.24.099220240992Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related GenesFan YANG0Nongyan WANG1Meng FANG2Yingjiao ZHANG3Haiyan HU4Peng FANG5Department of General Medicine, No. 903 Hospital of PLA Joint Logistic Support Force (Affiliated Xihu Hospital of Hangzhou Medical College), Hangzhou 310012, ChinaDepartment of General Medicine, No. 903 Hospital of PLA Joint Logistic Support Force (Affiliated Xihu Hospital of Hangzhou Medical College), Hangzhou 310012, ChinaDepartment of General Medicine, No. 903 Hospital of PLA Joint Logistic Support Force (Affiliated Xihu Hospital of Hangzhou Medical College), Hangzhou 310012, ChinaDepartment of General Medicine, No. 903 Hospital of PLA Joint Logistic Support Force (Affiliated Xihu Hospital of Hangzhou Medical College), Hangzhou 310012, ChinaDepartment of General Medicine, No. 903 Hospital of PLA Joint Logistic Support Force (Affiliated Xihu Hospital of Hangzhou Medical College), Hangzhou 310012, ChinaDepartment of General Medicine, No. 903 Hospital of PLA Joint Logistic Support Force (Affiliated Xihu Hospital of Hangzhou Medical College), Hangzhou 310012, ChinaObjectiveTo construct a prognostic model of lung adenocarcinoma (LUAD) based on m5C modification-related genes and to explore its clinical value. MethodsBased on the LUAD data in TCGA, GSE30219, GSE31210, and GSE50081 cohorts, prognosis-related m5C modification-related genes were screened, and the prognostic model was constructed by using univariate Cox, Lasso, and multivariate Cox regression analyses. Kaplan-Meier curve, ROC curve, and Cox regression were used to observe the robustness and prognostic performance of the model. The correlation between the prognostic model and clinicopathologic features was further explored. ResultsA prognostic model consisting of eight m5C modification-related genes, including CDK1, CDKN1A, NOP2, RRM2, TCL6, TLR8, TRDMT1, and YTHDF2, was constructed. Risk score was an independent risk factor for the prognosis of patients with LUAD, and it is combined with age, T stage, and N stage to constitute a nomogram which can accurately predict the prognosis of patients. The infiltration of macrophages and CD4+/CD8+T cells was significantly reduced in high-risk patients. The risk score in LUAD tissues was significantly higher than that in normal tissues and was positively correlated with T stage and N stage. The risk score of smoking and EGFR wild-type patients was higher than that of non-smoking and EGFR-mutant patients. ConclusionThe prognostic model constructed based on m5C modification-related genes has shown good accuracy and stability in predicting the prognosis of patients with LUAD, and it is closely related to clinical features, driver gene mutations, and immune infiltration, which can provide a potential basis for the treatment and prognostic assessment of LUAD.http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0992lung adenocarcinomamethylation modificationm5cprognosis modelrisk scorenomogram
spellingShingle Fan YANG
Nongyan WANG
Meng FANG
Yingjiao ZHANG
Haiyan HU
Peng FANG
Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes
Zhongliu Fangzhi Yanjiu
lung adenocarcinoma
methylation modification
m5c
prognosis model
risk score
nomogram
title Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes
title_full Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes
title_fullStr Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes
title_full_unstemmed Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes
title_short Construction and Validation of A Prognostic Model of Lung Adenocarcinoma Based on m5C Modification-Related Genes
title_sort construction and validation of a prognostic model of lung adenocarcinoma based on m5c modification related genes
topic lung adenocarcinoma
methylation modification
m5c
prognosis model
risk score
nomogram
url http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0992
work_keys_str_mv AT fanyang constructionandvalidationofaprognosticmodeloflungadenocarcinomabasedonm5cmodificationrelatedgenes
AT nongyanwang constructionandvalidationofaprognosticmodeloflungadenocarcinomabasedonm5cmodificationrelatedgenes
AT mengfang constructionandvalidationofaprognosticmodeloflungadenocarcinomabasedonm5cmodificationrelatedgenes
AT yingjiaozhang constructionandvalidationofaprognosticmodeloflungadenocarcinomabasedonm5cmodificationrelatedgenes
AT haiyanhu constructionandvalidationofaprognosticmodeloflungadenocarcinomabasedonm5cmodificationrelatedgenes
AT pengfang constructionandvalidationofaprognosticmodeloflungadenocarcinomabasedonm5cmodificationrelatedgenes